Masimo to Present at the Cowen and Company Health Care Conference |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Masimo, Inc.
2852 Kelvin Ave.
Irvine, CA, 92614
USA
Press release date: February 22, 2011
IRVINE, Calif., Feb. 22, 2011 - Masimo (Nasdaq: MASI) today announced that its management is scheduled to present at the Cowen and Company Health Care Conference at The Marriott Copley Place in Boston on Tuesday, March 8, 2011, at 8:45 a.m. E.T. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
About Masimo
Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care--helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry(TM), allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb®), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). In 2009, Masimo introduced rainbow Acoustic Monitoring(TM), the first-ever noninvasive and continuous monitoring of acoustic respiration rate (RRa(TM)). Masimo's rainbow SET platform offers a breakthrough in patient safety by helping clinicians detect life-threatening conditions and helping guide treatment options. Founded in 1989, Masimo has the mission of "Improving Patient Outcome and Reducing Cost of Care ... by Taking Noninvasive Monitoring to New Sites and Applications®." Additional information about Masimo and its products may be found at www.masimo.com.
SOURCE Masimo Corporation
CONTACT: investors, Sheree Aronson, Vice President, Investor Relations, +1-949-297-7043, saronson@masimo.com, or media, Dana Banks, Manager, Public Relations, +1-949-297-7348, dbanks@masimo.com, both of Masimo Corporation
Web Site: http://www.masimo.com
|
|
|
|
|
|
| 
